Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc. (PYNKF) Financial Performance & Income Statement Overview
Review Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Perimeter Medical Imaging AI, Inc. (PYNKF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Perimeter Medical Imaging AI, Inc. PYNKF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $550269.00 | $293133.00 | $208420.00 | $246311.00 |
| Cost of Revenue | $250892.00 | $104268.00 | $81333.00 | $74585.00 |
| Gross Profit | $299377.00 | $188865.00 | $127087.00 | $171726.00 |
| Gross Profit Ratio | $0.54 | $0.64 | $0.61 | $0.70 |
| R&D Expenses | $1.60M | $1.88M | $1.53M | $1.80M |
| SG&A Expenses | $2.91M | $2.64M | $2.88M | $3.55M |
| Operating Expenses | $4.64M | $4.54M | $4.53M | $5.47M |
| Total Costs & Expenses | $4.89M | $4.65M | $4.61M | $5.55M |
| Interest Income | $0.00 | $69165.00 | $27742.00 | $84470.00 |
| Interest Expense | $5800.00 | $5448.00 | $5909.00 | $7331.00 |
| Depreciation & Amortization | $207413.00 | $210870.00 | $188964.00 | $174631.00 |
| EBITDA | -$4.10M | -$3.21M | -$4.48M | -$3.00M |
| EBITDA Ratio | -$7.46 | -$10.94 | -$21.48 | -$12.17 |
| Operating Income | -$4.34M | -$4.36M | -$4.40M | -$5.22M |
| Operating Income Ratio | -$7.88 | -$14.86 | -$21.13 | -$21.18 |
| Other Income/Expenses (Net) | $21713.00 | $934122.00 | -$268010.00 | $2.04M |
| Income Before Tax | -$4.32M | -$3.42M | -$4.67M | -$3.18M |
| Income Before Tax Ratio | -$7.85 | -$11.67 | -$22.41 | -$12.91 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.32M | -$3.42M | -$4.67M | -$3.18M |
| Net Income Ratio | -$7.85 | -$11.67 | -$22.41 | -$12.91 |
| EPS | -$0.05 | -$0.05 | -$0.07 | -$0.05 |
| Diluted EPS | -$0.05 | -$0.05 | -$0.07 | -$0.05 |
| Weighted Avg Shares Outstanding | $93.51M | $71.49M | $65.06M | $65.06M |
| Weighted Avg Shares Outstanding (Diluted) | $93.51M | $71.49M | $65.06M | $65.06M |
Financial performance has remained strong, with revenue growing from $246311.00 in Q2 2024 to $550269.00 in Q1 2025. Gross profit continued to perform well, with margins at 54% in the latest quarter. Operating income reached -$4.34M in Q1 2025, holding a steady -788% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$4.10M. Net income dropped to -$4.32M, keeping EPS at -$0.05. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan